[Abstract Only] Randomized Trial: Satralizumab for Neuromyelitis Optica Spectrum Disorder
21 Jan, 2020 | 01:05h | UTCTrial of Satralizumab in Neuromyelitis Optica Spectrum Disorder – New England Journal of Medicine (link to abstract – $ for full-text)